Islet amyloid polypeptide in Psammomys obesus (sand rat): Effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment

Pancreas

Volumn 15, Issue 4, 1997, Pages 358-366

  Leckstrom A ^a   Ziv, E ^b   Shafrir, E ^b   Westermark, P ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

High energy diet; Immunohistochemistry; Insulin; Islet amyloid polypeptide; Psammomys obesus; Vanadyl sulfate

Indexed keywords

AMYLIN; GLUCOSE; INSULIN; VANADYL SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GERBIL; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULINEMIA; LOW CALORY DIET; NEGATIVE FEEDBACK; NONHUMAN; NUTRITION; PANCREAS ISLET; PEROXIDASE ANTIPEROXIDASE COMPLEX; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030735942     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199711000-00005     Document Type: Article

References (58)

1. Westermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986;140:827-31.
2. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH. Islet amyloid in type 2 diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 1987;127:414-7.
3. Cooper GJS, Willis AC, Clark A, Turner RC, Sim SB, Reid KBM. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987;84:8628-32.
4. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987;84:3881-5.
5. de Koning EJP, Bodkin JL, Hansen BC, Clark A. Diabetes mellitus in Macaca mulatta monkeys is characterized by islet amyloidosis and reduction in beta-cell population. Diabetologia 1993;36:378-84.
6. Johnson KH, O'Brien TD, Hayden DK, et al. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells using peroxidase antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol 1988;130:1-8.
7. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 1989;32:240-4.
8. Clark A, Edwards C, Ostle L, et al. Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects. Cell Tissue Res 1989;257:179-85.
9. Westermark P, Engström U, Westermark GT, Johnson KH, Permert J, Betsholtz C. Islet amyloid polypeptide (IAPP) and proIAPP immunoreactivity in human islets of Langerhans. Diabetes Res Clin Pract 1989;7:219-26.
10. Kanatsuka A, Makino H, Ohsawa H, et al. Secretion of islet amyloid polypeptide in response to glucose. FEBS Lett 1989;259:199-201.
11. Fehmann HC, Weber V, Göke R, Göke B, Arnold R. Cosecretion of amylin and insulin from isolated rat pancreas. FEBS Lett 1990; 262:279-81.
12. Kahn SE, d'Alessio DD, Schwartz MW, et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 1990;39:634-8.
13. Hartter E, Svoboda T, Ludvik B, et al. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 1991;32:52-4.
14. Molina JM, Cooper GJS, Dimitriadis GD. Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes 1990;260-4.
15. Sowa R, Sanke T, Hirayama J, et al. Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 1990;33:118-20.
16. Leighton B, Cooper GJS. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 1988;335:632-5.
17. Cooper GJS, Leighton B, Dimitriadis GD, et al. Amylin found in deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci USA 1988;85:7763-6.
18. Johnson KH, O'Brien TD, Betsholtz C, Westermark P. Islet amyloid, islet amyloid polypeptide, and diabetes mellitus. N Engl J Med 1989;321:513-8.
19. Groop LC, Eriksson JG. The etiology and pathogenesis of non-insulin-dependent diabetes. Ann Med 1992;24:483-9.
20. Luskey KL. Possible links between amylin and diabetes. Diabetes Care 1992;41:297-9.
21. Westermark P, Johnson KH, O'Brien TD, Betsholtz C. Islet amyloid polypeptide - a novel controversy in diabetes research. Diabetologia 1992;35:1-7.
22. Wolffenbuttel BHR, Van Haeften TW. Non-insulin dependent diabetes mellitus: defects in insulin secretion. Eur J Clin Invest 1993; 23:69-79.
23. Porte D Jr. β-cells in type II diabetes mellitus. Diabetes 1991;40: 166-80.
24. Cooper GJS. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev 1994;15:163-201.
25. Panagiotidis G, Salchi AA, Westermark P, Lundquist I. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse. Diabetes Res Clin Pract 1992;18:167-71.
26. Åkesson B, Panagiotidis G, Westermark P, Lundquist I. The nature of the stimulus determines the effects of IAPP on islet hormone release. Pharmacol Toxicol 1995;76 (Suppl IV).
27. Schmidt-Nielsen K, Haines HB, Hackel DB. Diabetes mellitus in the sand rat induced by standard laboratory diets. Science 1964; 143:689-90.
28. Kalderon B, Gutman A, Levy E, Shafrir E, Adler JH. Characterization of stages in development of obesity-diabetes syndrome in sand rat (Psammomys obesus). Diabetes 1986;35:717-23.
29. Shafrir E, Gutman A. Psammomys obesus of the Jerusalem colony: a model for nutritionally induced non-insulin-dependent diabetes. J Basic Clin Physiol Pharmacol 1993;4:83-99.
30. Ziv E, Shafrir E. Psammomys obesus nutritionally induced NIDDM-like syndrome on a "thrifty gene" background. In: Shafrir E, ed. Lessons from animal diabetes. London: Smith-Gordon, 1995:285-305.
31. Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinemia. Diabetes Metab 1996;22:122-31.
32. Kaiman R, Adler JH, Lazarovici G, Bar-On H, Ziv E. The efficiency of sandrat metabolism is responsible for the development of obesity and diabetes. J Basic Clin Physiol Pharmacol 1993;4:57-68.
33. Pederson RA, Ramanadham S, Buchan AMJ, McNeill JH. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats. Diabetes 1989;38:1390-5.
34. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH. Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol 1989;257:H904-11.
35. Sternberger LA. The unlabelled antibody peroxydase-antiperoxydase (PAP) method. In: Sternberger LA, ed. Immunohistochemistry. New York: John Wiley, 1979:104-67.
36. Christmanson L, Betsholtz C, Leckström A, et al. Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis. Diabelologia 1993;36:183-8.
37. Kanety H, Moshe S, Shafrir E, Lunenfeld B, Karasik A. Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91: 1853-7.
38. Bendayan M, Malide D, Ziv E, et al. Immunocytochemical investigation of insulin secretion by pancreatic β-cells in control and diabetic Psammomys obesus. J Histochem Cytochem 1995;43:771-84.
39. Adler JH. Hyperglycemia and hyperinsulinemia in the sand rat (Psammomys obesus) with positive or negative energy balance. Isr J Med Sci 1982;18:187-91.
40. Barnett M, Collier GR, Zimmet P, O'Dea K. The effect of restricting energy intake on diabetes in Psammomys obesus. Int J Obes 1994;18:789-94.
41. Barnett M, Collier GR, Zimmet P, O'Dea K. Energy intake with respect to the development of diabetes mellitus in Psammomys obesus. Diab Nutr Metab 1995;8:42-7.
42. Kalderon B, Asler JH, Levy E, Gutman A. Lipogenesis in the sand rat (Psammomys obesus). Am J Physiol 1983;244:E480-6.
43. Inoue K, Hiramatsu S, Hisatomi A, Umeda F, Nawata H. Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging. Metabolism 1993; 42:654-8.
44. Duhault J, Boulanger M, Espinal J, et al. Islet amyloid polypeptide in Psammomys obesus: lack of correlation between insulin resistance and plasma IAPP levels. Cell Mol Biol 1994;40:535-40.
45. Mongold JJ, Cros GH, Vian L, et al. Toxicological aspects of vanadyl sulphate treatment on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology. Pharmacol Toxicol 1990; 67:192-8.
46. Domingo JL, Mercedes G, Llobet JM, Corbella J, Keen CL. Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects. Pharmacol Toxicol 1991;68:249-53.
47. Thompson KH, Leichter J, McNeill JH. Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats. Biochem Biophys Res Commun 1993;197:1549-55.
48. Cohen N, Halberstam M, Shlimovich P, et al. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1995;95: 2501-9.
49. Boden G, Xinhua C, Ruiz J, van Rossum GDV, Turco S. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 1996; 45:1130-5.
50. Inoue K, Hisatomi A, Umeda F, Nawata H. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment. Diabetes 1992;41:723-7.
51. Hiramatsu S, Inoue K, Sako Y, Umeda F, Nawata H. Insulin treatment improves relative hypersecretion of amylin to insulin in rats with non-insulin-dependent diabetes mellitus induced by neonatal streptozocin injection. Metabolism 1994;43:766-70.
52. Leckström A, Ostenson C-G, Efendić S, et al. Increased storage and secretion of islet amyloid polypeptide relative to insulin in the spontaneously diabetic GK rat. Pancreas 1996;13:259-67.
53. Silvestre RA, Peiró E, Dégano P, Miralles P, Marco J. Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept 1990;31:23-31.
54. Kogire M, Ishizuka J, Thompson JC, Greeley GH Jr. Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas. Pancreas 1991;6:459-63.
55. Starich GH, Zafirova M, Jablenska R, Petkov P, Lardinois CK. A morphological and immunohistochemical investigation of endocrine pancreata from obese ob/ob mice. Acta Histochem 1991;90: 93-101.
56. Donev S, Petkov P, Marquié G, Duhault J, Jablenska R. Immunohistochemical investigations of the endocrine pancreas in normoglycemic sand rats (Psammomys obesus). Acta Diabetol Lat 1989; 26:309-13.
57. Marquié G, Petkov P, Duhault J. Diabetic syndrome in sand rats (Psammomys obesus) with special reference to the pancreas. Abstracts Diabetol 1980;19:297.
58. Petkov P, Hadjiisky P, Marquié G. Pancreatic islet histochemistry in normal sand rats (Psammomys obesus). Cell Mol Biol 1981;27: 655-66.